Feihe
sells the Xingfeifan Stage-3 (12-36 month) formula using a patented OPO structured lipid designed to mimic breast-milk fat structure and reduce calcium-soap formation, paired with A2 beta-casein milk and probiotic strains (including strain BB536) selected for compatibility with a toddler's gut;…
- Country
- China
Commercial
Xingfeifan Stage-3 (12-36mo) OPO structured-lipid, A2 beta-casein, probiotic strain BB536
cn
Coverage
| CN | EU | US | |
|---|---|---|---|
| food-alt-protein | ✓ | ✓ | ✓ |
Regulatorsfdareachnmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Bio-toddler nutrition | food-alt-protein | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.